Interestingly, while the cytokine IL-6, known to be associated with cardiac myxomas [27], is often correlated with lower hemoglobin levels in the context of COVID-19 [29], no substantial data exist on its direct impact on embolism in myxoma patients. The gene discussed is IL6; the disease is myxoma.